MarketPeel
CG

Carl L. Gordon

ORIC
DIRECTOR · ORIC PHARMACEUTICALS, INC. · CIK 0001282930
FILING MIX · LIFETIME65%/35%
BUYS
91
SELLS
48
TOTAL VALUE
$139.91M
COMPANIES
9
ACTIVE SINCE
Apr 2020
HOLDINGS NOW
19,449,634
AVG SELL PX
$7.76
TRADE KIND
SHOWING 139 / 139
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
33 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Carl L. Gordon, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d33+66.67%+5.19%-0.14%+5.33%-0.70%1.40
14d33+69.70%+4.96%-0.33%+5.28%-9.71%1.14
30d33+72.73%+5.99%+1.25%+4.74%-4.06%0.93
60d33+69.70%+9.16%+0.95%+8.21%-10.84%1.30
90d33+45.45%-10.15%+4.10%-14.25%-22.62%-2.98
180d33+63.64%+14.99%+8.13%+6.87%-13.60%0.56
1y33+63.64%-24.78%+16.05%-40.83%-73.36%-3.45
2y33(2 pending)+61.29%-38.63%+30.58%-69.21%-85.66%-6.44
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ORIC · 16,625 shares · as of Jun 16, 2021
0691,4291,382,8592,074,2882,765,7172021SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 91 buys / 48 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SCTX
SCRIBE THERAPEUTICS, INC.
PURCHASE
1,000,000$15.00$15.00M1,348,825Jul 27, 2026Jul 29, 2026View →
SCTX
SCRIBE THERAPEUTICS, INC.
PURCHASE
348,825348,825Jul 27, 2026Jul 29, 2026View →
SCTX
SCRIBE THERAPEUTICS, INC.
SALE
2,065,6720Jul 27, 2026Jul 29, 2026View →
SCTX
SCRIBE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,72514,725Jul 23, 2026Jul 27, 2026View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
90,00090,000Jan 2, 2026Jan 5, 2026View →
KROS
KEROS THERAPEUTICS, INC.
SALE
140,057$17.75$2.49M759,155Nov 21, 2025Dec 18, 2025View →
KROS
KEROS THERAPEUTICS, INC.
SALE
74,465$17.75$1.32M45,057Nov 21, 2025Dec 18, 2025View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,50010,500Jun 4, 2025Jun 6, 2025View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,2505,250Jun 4, 2025Jun 6, 2025View →
CMPX
COMPASS THERAPEUTICS, INC.
SALE
3,571,428$1.59$5.68M0Apr 9, 2025Apr 11, 2025View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
94,100$10.84$1.02M747,887Feb 18, 2025Feb 19, 2025View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
49,070$10.84$531.9K3,255,000Feb 18, 2025Feb 19, 2025View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
29,540$9.85$291.0K3,205,930Feb 14, 2025Feb 19, 2025View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
17,962$9.90$177.8K3,176,390Feb 14, 2025Feb 19, 2025View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,00040,000Feb 11, 2025Feb 13, 2025View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
500,000$16.00$8.00M3,158,428Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
250,000$16.00$4.00M653,787Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
403,787403,787Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
2,658,4282,658,428Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
SALE
4,854,3680Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
SALE
12,372,6340Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
SALE
19,587,2840Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
15,96315,963Sep 12, 2024Sep 13, 2024View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
26,40026,400Aug 21, 2024Aug 23, 2024View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
30,00030,000Aug 21, 2024Aug 23, 2024View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
18,50018,500Aug 21, 2024Aug 23, 2024View →
ACET
ADICET BIO, INC.
SALE
26,4000Aug 21, 2024Aug 23, 2024View →
ACET
ADICET BIO, INC.
SALE
18,5000Aug 21, 2024Aug 23, 2024View →
ACET
ADICET BIO, INC.
SALE
30,0000Aug 21, 2024Aug 23, 2024View →
KROS
KEROS THERAPEUTICS, INC.
SALE
220,600$44.01$9.71M899,212Aug 13, 2024Aug 15, 2024View →
KROS
KEROS THERAPEUTICS, INC.
SALE
29,400$44.01$1.29M119,522Aug 13, 2024Aug 15, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
556$10.00$5.6K1,967,924Jul 16, 2024Jul 17, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
4,009$10.00$40.1K4,839,412Jul 16, 2024Jul 17, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
623$10.00$6.2K755,635Jul 16, 2024Jul 17, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
5,401$10.00$54.0K1,968,480Jul 15, 2024Jul 17, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
6,142$10.00$61.4K756,258Jul 15, 2024Jul 17, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
39,433$10.00$394.3K4,843,421Jul 15, 2024Jul 17, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
4,6764,676Jul 1, 2024Jul 2, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
32,00032,000Jun 10, 2024Jun 14, 2024View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
5,90011,800Jun 5, 2024Jun 7, 2024View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
26,40026,400Jun 5, 2024Jun 7, 2024View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,00010,000May 30, 2024Jun 3, 2024View →
PHGE
BIOMX INC.
SALE
9,280,4080May 15, 2024May 20, 2024View →
PHGE
BIOMX INC.
PURCHASE
9,280,408$0.24$2.26M13,797,997May 15, 2024May 20, 2024View →
PHGE
BIOMX INC.
SALE
24,344$0.38$9.3K13,773,653May 15, 2024May 20, 2024View →
PHGE
BIOMX INC.
PURCHASE
4,3274,327Mar 15, 2024Mar 19, 2024View →
PHGE
BIOMX INC.
PURCHASE
2,163,5002,163,500Mar 15, 2024Mar 19, 2024View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,00040,000Feb 9, 2024Feb 14, 2024View →
AVBP
ARRIVENT BIOPHARMA, INC.
PURCHASE
821,827821,827Jan 30, 2024Jan 31, 2024View →
AVBP
ARRIVENT BIOPHARMA, INC.
SALE
469,6150Jan 30, 2024Jan 31, 2024View →
AVBP
ARRIVENT BIOPHARMA, INC.
SALE
821,8270Jan 30, 2024Jan 31, 2024View →
AVBP
ARRIVENT BIOPHARMA, INC.
PURCHASE
469,6151,291,442Jan 30, 2024Jan 31, 2024View →
AVBP
ARRIVENT BIOPHARMA, INC.
PURCHASE
222,222$18.00$4.00M1,513,664Jan 30, 2024Jan 31, 2024View →
ACET
ADICET BIO, INC.
PURCHASE
242,200$2.40$581.3K990,254Jan 25, 2024Jan 26, 2024View →
ACET
ADICET BIO, INC.
PURCHASE
1,841,100$2.40$4.42M7,526,359Jan 25, 2024Jan 26, 2024View →
ACET
ADICET BIO, INC.
PURCHASE
1,041,700$2.40$2.50M1,255,985Jan 25, 2024Jan 26, 2024View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
26,40026,400Aug 14, 2023Aug 16, 2023View →
ACET
ADICET BIO, INC.
SALE
26,4000Aug 14, 2023Aug 16, 2023View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
30,00030,000Aug 14, 2023Aug 16, 2023View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
18,50018,500Aug 14, 2023Aug 16, 2023View →
ACET
ADICET BIO, INC.
SALE
18,5000Aug 14, 2023Aug 16, 2023View →
ACET
ADICET BIO, INC.
SALE
30,0000Aug 14, 2023Aug 16, 2023View →
ACET
ADICET BIO, INC.
PURCHASE
250,000$2.09$522.5K646,657Jun 27, 2023Jun 29, 2023View →
ACET
ADICET BIO, INC.
PURCHASE
125,000$2.09$261.3K1,027,885Jun 27, 2023Jun 29, 2023View →
ACET
ADICET BIO, INC.
PURCHASE
58,000$2.09$121.2K748,054Jun 27, 2023Jun 29, 2023View →
ACET
ADICET BIO, INC.
PURCHASE
442,000$2.09$923.8K5,685,259Jun 27, 2023Jun 29, 2023View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
32,00032,000Jun 12, 2023Jun 14, 2023View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,00010,000Jun 6, 2023Jun 8, 2023View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
26,40026,400Jun 1, 2023Jun 2, 2023View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
5,9005,900Jun 1, 2023Jun 2, 2023View →
PHGE
BIOMX INC.
PURCHASE
348,000$0.25$85.3K3,161,489Feb 27, 2023Mar 17, 2023View →
PHGE
BIOMX INC.
PURCHASE
1,789,9591,789,959Feb 27, 2023Mar 17, 2023View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
60,00060,000Feb 8, 2023Feb 9, 2023View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
137,931$7.25$1000.0K4,882,854Dec 23, 2022Dec 28, 2022View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
402,000$3.21$1.29M15,219,994Nov 8, 2022Nov 10, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
207,500207,500Aug 16, 2022Aug 18, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
2,470,200$2.42$5.98M4,744,923Aug 16, 2022Aug 18, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
457,400$2.42$1.11M1,973,881Aug 16, 2022Aug 18, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
38,45038,450Aug 16, 2022Aug 18, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
762,400$2.42$1.85M762,400Aug 16, 2022Aug 18, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
64,05064,050Aug 16, 2022Aug 18, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
32,00032,000Jun 16, 2022Jun 21, 2022View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
18,50018,500Jun 2, 2022Jun 3, 2022View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,2938,293Jun 1, 2022Jun 3, 2022View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
30,722$2.49$76.5K14,817,994May 13, 2022May 13, 2022View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
97,094$2.35$228.2K14,787,272May 12, 2022May 13, 2022View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
64,700$1.79$115.8K14,690,178May 11, 2022May 13, 2022View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
24,447$1.60$39.1K14,625,478May 10, 2022May 10, 2022View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
90,712$1.56$141.5K14,601,031May 9, 2022May 10, 2022View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
10,200$1.63$16.6K14,510,319May 6, 2022May 10, 2022View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,00030,000Feb 18, 2022Feb 23, 2022View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
214,285$14.00$3.00M242,285Dec 10, 2021Dec 14, 2021View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
3,571,428$3.50$12.50M3,571,428Nov 4, 2021Nov 8, 2021View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
1,785,715$3.50$6.25M14,500,119Nov 4, 2021Nov 8, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
16,62516,625Jun 16, 2021Jun 17, 2021View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,2938,293Jun 1, 2021Jun 3, 2021View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
18,50018,500Apr 30, 2021May 4, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
27,869$23.93$666.9K2,212,571Mar 30, 2021Mar 31, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
75,555$23.31$1.76M2,240,440Mar 29, 2021Mar 31, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
27,816$23.88$664.2K2,315,995Mar 26, 2021Mar 26, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
51,523$24.70$1.27M2,343,811Mar 25, 2021Mar 26, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
32,959$24.80$817.4K2,395,334Mar 24, 2021Mar 26, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
3,992$24.32$97.1K2,428,293Mar 23, 2021Mar 23, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
7,673$26.47$203.1K2,432,285Mar 22, 2021Mar 23, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
21,275$26.47$563.1K2,439,958Mar 19, 2021Mar 23, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
6,059$28.03$169.8K2,461,233Mar 18, 2021Mar 18, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
18,790$28.43$534.2K2,467,292Mar 17, 2021Mar 18, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
41,353$27.72$1.15M2,486,082Mar 16, 2021Mar 18, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
89,210$29.14$2.60M2,527,435Mar 15, 2021Mar 15, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
90,521$30.29$2.74M2,616,645Mar 12, 2021Mar 15, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
58,551$33.04$1.93M2,707,166Mar 11, 2021Mar 15, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
25,00025,000Feb 24, 2021Feb 26, 2021View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
104,050$13.00$1.35M396,657Feb 12, 2021Feb 18, 2021View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
420,299$13.00$5.46M5,243,259Feb 12, 2021Feb 18, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
1,326,4811,326,481Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
1,071,4280Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
918,2950Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
1,989,7231,989,723Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
285,000$17.00$4.84M2,274,723Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
612,1960Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
190,000$17.00$3.23M1,516,481Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
714,2850Feb 9, 2021Feb 9, 2021View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
30,00030,000Sep 17, 2020Sep 17, 2020View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
4,822,9604,822,960Sep 15, 2020Sep 17, 2020View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
292,607292,607Sep 15, 2020Sep 17, 2020View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
902,885902,855Sep 15, 2020Sep 17, 2020View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
373,3562,529,606Apr 28, 2020Apr 28, 2020View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
373,3560Apr 28, 2020Apr 28, 2020View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
236,1112,765,717Apr 28, 2020Apr 28, 2020View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
1,875,0002,156,250Apr 28, 2020Apr 28, 2020View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
1,875,0000Apr 28, 2020Apr 28, 2020View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
236,1110Apr 28, 2020Apr 28, 2020View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
281,250$16.00$4.50M281,250Apr 24, 2020Apr 28, 2020View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
16,62516,625Apr 23, 2020Apr 27, 2020View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASE
375,200$16.00$6.00M1,119,812Apr 13, 2020Apr 13, 2020View →
KROS
KEROS THERAPEUTICS, INC.
SALE
744,6120Apr 13, 2020Apr 13, 2020View →
KROS
KEROS THERAPEUTICS, INC.
SALE
148,9220Apr 13, 2020Apr 13, 2020View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASE
148,922148,922Apr 13, 2020Apr 13, 2020View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASE
744,612744,612Apr 13, 2020Apr 13, 2020View →
Other insiders · ORIC
Loading peer insiders…
About this filer
CIK 0001282930
ROLE
Director
PRIMARY
ORIC
COMPANIES
9
ACTIVE SINCE
Apr 2020
MARKETPEEL · /INSIDER/0001282930DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback